張志將，男，博士，湖北省預防醫學會心血管疾病預防與控制專業委員會委員，International Journal of Molecular Epidemiology and Genetics 雜誌編委。
基本介紹
- 中文名：張志將
- 性別：男
主要研究課題：
3. 全英文教學、"以問題為基礎"（Problem-based learning）教學
代表性論著 ：
1. Zhang ZJ, Bi Y, Li S, Zhang Q, Zhao G, Guo Y, Song Q. Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis. Am J Epidemiol 2014;180(1):11-4.
2. Zhang ZJ, Li S. The prognostic value of metformin for cancer patients with concurrent diabetes- a systematic review and meta-analysis. Diabetes Obes Metab 2014; 16(8):707-10.
3. Zhang ZJ, Zhao G, Song Y. Attention is needed for women in the control of diabetic complications in China. Acta Diabetol. 2014 May 13. [Epub ahead of print]
4. Zhang ZJ, Zhao G, Bi Y. Letter to the Editor: regarding "Temporal trend of mortality rate for diabetes among colorectal cancer patients from 1975 to 2009" . Ann Epidemiol 2014. [Epub ahead of print].
5. Zhang ZJ, Zhao G, Bi Y, et al. Diabetic women suffer more years of life loss than diabetic men. International Journal of Endocrinology 2014. [Epub ahead of print]
6. Zhang ZJ, Sun J, Xiang H, Bao M. Mortality Risk after Stent Post-dilation. Heart Lung Circ 2014; 23(8):786.
7. Zhang ZJ. RE: "TYPE 2 DIABETES AND THE RISK OF COLORECTAL ADENOMAS: BLACK WOMEN'S HEALTH STUDY". Am J Epidemiol 2014; 179(10): 1276-7.
8. Mei ZB, Zhang ZJ, Liu CY, Liu Y, Cui A, Liang ZL, Wang GH, Cui L.Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis. PLoS One 2014;9(3):e91818.
9. Zhang ZJ. The association between type 2 diabetes and head and neck squamous cell carcinoma. Cancer Epidemiol 2014;38(2):209.
10. Zhang ZJ, Marroquin OC, Stone RA, Weissfeld JL, Mulukutla SR, Selzer F, Kip KE. The effect of stent post-dilation in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction. Heart Lung Circ 2013; 22(9):787-8.
11. Zhang ZJ. Systematic review on the association between F2-isoprostanes and cardiovascular disease. Annals of Clinical Biochemistry 2013;50(Pt 2):108-14.
12. Zhang ZJ, Zheng ZJ, Shi R, Su Q, Jiang Q, Kip KE. Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Journal of Clinical Endocrinology & Metabolism 2012;97(7):2347-53.
13. Zhang ZJ, Zheng ZJ, Kan H, Song Y, Cui W, Zhao G, Kip KE. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes-a meta-analysis. Diabetes Care 2011; 34(10):2323-8.
14. Xu X, Nembhard WN, Kan H, Kearney G, Zhang ZJ, Talbott EO. Urinary trichlorophenol levels and increased risk of attention deficit hyperactivity disorder among US school-aged children. Occup Environ Med 2011; 68(8):557-61.
15. Zhang ZJ, Hao K, Shi R, Zhao G, Jiang GX, Song Y, Xu X, Ma J. Glutathione S-Transferase M1 (GSTM1) and Glutathione S-Transferase T1 (GSTT1) Null Polymorphisms, Smoking, and Their Interaction in Oral Cancer: A HuGE Review and Meta-Analysis. American Journal of Epidemiology 2011; 173(8):847-57.
16. Zhang ZJ. Mortality benefit and reduced need for repeat revascularization with statin therapy among patients undergoing percutaneous coronary intervention. Journal of Cardiology 2011; 57(3):360.
17. Zhang ZJ, Marroquin OC, Stone RA, Weissfeld JL, Mulukutla SR, Selzer F, Kip KE. Differential effects of post-dilation following stent deployment in patients presenting with and without acute myocardial infarction. American Heart Journal 2010, 160(5):979-86.
18. Zhang ZJ, Cheng Q, Jiang GX, Marroquin OC. Statins in prevention of repeat revascularization after percutaneous coronary intervention-A meta-analysis of randomized clinical trial. Pharmacological Research 2010; 61(4):316-20.
19. Zhang ZJ, Marroquin OC, Weissfeld JL, Stone RA, Mulukutla SR, Williams DO, Selzer F, Kip KE. Beneficial effects of statins after percutaneous coronary intervention. European Journal of Cardiovascular Prevention and Rehabilitation 2009; 16(4): 445-50.
20. 張志將, 雷正龍，謝錚，尹慧，郭岩. 全球消滅脊髓灰質炎行動25周年的回顧與展望：消滅最後的千分之一. 中國全科醫學, 2014, 17(27):3167-70.
21. 張志將, 李十月，燕虹，鄒宇量，郭毅，向浩，陳華，毛宗福. 建構主義在流行病學教學上的套用. 中國高等醫學教育, 2014, 2:16-7.
22. 張志將, 林松柏, 趙根明, 韓明. 上海市1971～2000年糖尿病引起的疾病負擔趨勢分析. 中華預防醫學雜誌 2004; 38(5): 338.
23. 張志將, 趙根明, 吳元民, 江萍. 人體測量指標和糖尿病危險狀態指標的相關關係; 中國公共衛生 2002;689-690.
24. 張志將, 吳元民, 江萍，趙根明. 社區自然人群中糖尿病慢性併發症危險因素的探索研究. 中國全科醫學 2001; 4(12)：970-972.
7. Zhang ZJ. RE: "TYPE 2 DIABETES AND THE RISK OF COLORECTAL ADENOMAS: BLACK WOMEN'S HEALTH STUDY". Am J Epidemiol 2014; 179(10): 1276-7.
8. Mei ZB, Zhang ZJ, Liu CY, Liu Y, Cui A, Liang ZL, Wang GH, Cui L.Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis. PLoS One 2014;9(3):e91818.
9. Zhang ZJ. The association between type 2 diabetes and head and neck squamous cell carcinoma. Cancer Epidemiol 2014;38(2):209.
10. Zhang ZJ, Marroquin OC, Stone RA, Weissfeld JL, Mulukutla SR, Selzer F, Kip KE. The effect of stent post-dilation in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction. Heart Lung Circ 2013; 22(9):787-8.
11. Zhang ZJ. Systematic review on the association between F2-isoprostanes and cardiovascular disease. Annals of Clinical Biochemistry 2013;50(Pt 2):108-14.
12. Zhang ZJ, Zheng ZJ, Shi R, Su Q, Jiang Q, Kip KE. Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Journal of Clinical Endocrinology & Metabolism 2012;97(7):2347-53.
13. Zhang ZJ, Zheng ZJ, Kan H, Song Y, Cui W, Zhao G, Kip KE. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes-a meta-analysis. Diabetes Care 2011; 34(10):2323-8.
14. Xu X, Nembhard WN, Kan H, Kearney G, Zhang ZJ, Talbott EO. Urinary trichlorophenol levels and increased risk of attention deficit hyperactivity disorder among US school-aged children. Occup Environ Med 2011; 68(8):557-61.
15. Zhang ZJ, Hao K, Shi R, Zhao G, Jiang GX, Song Y, Xu X, Ma J. Glutathione S-Transferase M1 (GSTM1) and Glutathione S-Transferase T1 (GSTT1) Null Polymorphisms, Smoking, and Their Interaction in Oral Cancer: A HuGE Review and Meta-Analysis. American Journal of Epidemiology 2011; 173(8):847-57.
16. Zhang ZJ. Mortality benefit and reduced need for repeat revascularization with statin therapy among patients undergoing percutaneous coronary intervention. Journal of Cardiology 2011; 57(3):360.
17. Zhang ZJ, Marroquin OC, Stone RA, Weissfeld JL, Mulukutla SR, Selzer F, Kip KE. Differential effects of post-dilation following stent deployment in patients presenting with and without acute myocardial infarction. American Heart Journal 2010, 160(5):979-86.
18. Zhang ZJ, Cheng Q, Jiang GX, Marroquin OC. Statins in prevention of repeat revascularization after percutaneous coronary intervention-A meta-analysis of randomized clinical trial. Pharmacological Research 2010; 61(4):316-20.
19. Zhang ZJ, Marroquin OC, Weissfeld JL, Stone RA, Mulukutla SR, Williams DO, Selzer F, Kip KE. Beneficial effects of statins after percutaneous coronary intervention. European Journal of Cardiovascular Prevention and Rehabilitation 2009; 16(4): 445-50.
20. 張志將, 雷正龍，謝錚，尹慧，郭岩. 全球消滅脊髓灰質炎行動25周年的回顧與展望：消滅最後的千分之一. 中國全科醫學, 2014, 17(27):3167-70.
21. 張志將, 李十月，燕虹，鄒宇量，郭毅，向浩，陳華，毛宗福. 建構主義在流行病學教學上的套用. 中國高等醫學教育, 2014, 2:16-7.
22. 張志將, 林松柏, 趙根明, 韓明. 上海市1971～2000年糖尿病引起的疾病負擔趨勢分析. 中華預防醫學雜誌 2004; 38(5): 338.
23. 張志將, 趙根明, 吳元民, 江萍. 人體測量指標和糖尿病危險狀態指標的相關關係; 中國公共衛生 2002;689-690.
24. 張志將, 吳元民, 江萍，趙根明. 社區自然人群中糖尿病慢性併發症危險因素的探索研究. 中國全科醫學 2001; 4(12)：970-972.
